[68Ga]Ga-FAPI-46 in Staging of Head and Neck Carcinomas

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

December 31, 2026

Conditions

Head and Neck Squamous Cell Carcinoma HNSCC

Interventions

DRUG

[68Ga]Ga-FAPI-46 PET/CT

\[68Ga\]Ga-FAPI-46 PET/CT

Trial Locations (1)

RECRUITING

Centre hospitalier universitaire vaudois, Lausanne

All Listed Sponsors

lead

John O. Prior

OTHER

NCT06794372 - [68Ga]Ga-FAPI-46 in Staging of Head and Neck Carcinomas | Biotech Hunter | Biotech Hunter